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Isolation and Culture of Pulmonary
Endothelial Cells
by Una S. Ryan*
Methods for isolation, identification and culture ofpulmonary endothelial cells are now routine. In the
past, methods ofisolation have used proteolytic enzymes todetach cells; thereafter, traditional methods for
cell passaging have used trypsin/EDTA mixtures. Cells isolated and passaged using proteolytic enzymes
have been useful in establishing the field and in verifying certain endothelial properties. However, there is a
growing awareness of the role of endothelial cells in processing vasoactive substances, in responding to
hormones and other agonists and in cell-cell interactions with other cell types ofthe vascular wall, with
blood cells and with cellular products. Consequently, a new requirement has arisen for cells in vitro that
maintain the differentiated properties oftheir counterparts in vivo. The deleterious effects oftrypsin and
other proteolytic enzymes commonly used in cell culture on surface structures ofendothelial cells such as
enzymes, receptors and junctional proteins, as well as on extracellular layers such as the glycocalyx or
"endothelial fuzz," have led tothedevelopment ofmethods that avoid use ofproteolytic enzymes at both the
isolation step and during subsequent subculture. This chapter describes traditional methods for isolating
pulmonary endothelial cells butemphasizes newerapproaches using mechanical harvest and scale-up using
microcarriers. The new methods allow maintenance of long-term, large-scale cultures of cells that retain
the full complement of surface properties and that maintain the cobblestone monolayer morphology and
differentiated functional properties. Methods for identification of isolated cells are therefore also
considered as methods for validation of cultures during their in vitro lifespan.
Introduction
The pulmonary endothelium is ideally situated as a
strategic command post for regulating the entry of
vasoactive substances into the systemic circulation
(1-3). Endothelial cells of the lungs are now known to
conduct a wide variety of specific metabolic activities
important in the pulmonary processing of vasoactive
substances. For example, enzymes, inhibitors, recep-
tors and transport systems of endothelial cells can
determine the levels of biogenic amines, kinins, angio-
tensins and prostaglandins entering the circulation
(1,4). In this way the pulmonary endothelium plays a
major role in the responses of target organs including
the lungs themselves.
Many ofthe original studies implicating a role for the
pulmonary endothelium were indirect, e.g., isolated
perfused lung preparations (5,6). One step which was
critical to ourunderstanding ofspecific metabolic activi-
ties of endothelial cells was the ability to isolate pure
lines of pulmonary endothelial cells and to propagate
them in culture. First, it is pertinent to consider the
anatomical features which characterize the pulmonary
vasculature.
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Anatomical Considerations
Endothelium of the lungs is of the continuous type
(3,7). From earlier studies (5,6,8) it appeared likely
that the site of the major processing of vasoactive
substances was likely to occur at the level of the
smallest vessels where circulating substrates would
have theirgreatest exposure to lungcells. However, itis
hard to imagine from conventional cross-sections at the
level ofthe alveolar capillary unit (Fig. 1) that endothe-
lial cells could play an active role in metabolizing
bloodborne substrates. As seen in Figure 2, even with
theresolvingpoweroftheelectronmicroscope, endothe-
lium in transverse section is extremely thin with few
apparent cytoplasmic organelles. It is not until the
extensiveness of the pulmonary capillary bed is taken
into account, together with the strategic position ofthe
lungs in the circulation, that one can appreciate the vast
surface area available for processing. Even so it is hard
to envisage how these cells, invisible except by electron
microscopy, could be made amenable to harvest and
culture.
Fortunately, the pulmonary artery of large animals
can be dissected out and the endothelial layer can be
removed by enzymatic digestion or by mechanical
means. Although there are many similarities ofthe cell
type in different locations it must be remembered that
there are structural and probably functional differencesU S. RYAN
FIGURE 1. Light micrograph of a rat lung which had been perfused free of blood. The alveolar-capillary unit (arrows) appears as a simple
membrane and the cellular nature of the barrier cannot be resolved (compare Fig. 2). x 650.
between endothelial cells derived from vessels ofdiffer-
ent organs, different regions of each vascular bed and
different species. For example, more projections,
Weibel-Palade Bodies and fibrils occur in endothelium of
large vessels than in those ofthe microvasculature (1,3)
(Figs. 2 and 5). Furthermore, the junctional organiza-
tion differs at different levels of the vascular tree and
gap junctions are absent between capillary endothelial
cells.
To a certain extent, developments and improvements
inboth isolation and culture procedures are still ongoing
but it is true to say that the establishment ofpulmonary
endothelial cultures is now routine and that the tech-
niques are reproducible and functioning in a number of
laboratories for a wide variety of applications.
To alarge extent the methods ofchoice depend on the
final goals to which the cultures are dedicated. For
example some studies require fresh isolates which
resemble as closely as possible the in vivo state, others
require vast numbers ofcells and depend on large-scale,
long-term production of endothelium. Furthermore,
concerns with respect to species and the size of vessel
from which the endothelium is derived must be taken
into account.
Basically, the methods for in vitro cultivation of
endothelial cells can be grouped as follows: (1) isolation
and harvest following perfusion with proteolytic en-
zymes: (a) to obtain endothelium from large vessels of
large animals and (b) to obtain endothelium from small
vessels of small animals (this latter technique is adapt-
able for obtaining endothelial cells from a lobe of lung,
including human lung obtained by open biopsy); (2)
culture and subculture by routine state-of-the art
methods; (3) isolation and harvest avoiding the use of
proteolytic enzymes; (4) long-term, large-scale culture
avoiding the use of enzymes.
Whichever method or combination of methods is
chosen, endothelial cells, in common with all cells
maintained in vitro, must be characterized by rigorous
criteria. First, they must be identified once they are no
longer in the vessel and second they must be assessed
for the maintenance of differentiated characteristics
after long periods in culture. As a result of studies
originally aimed at improving understanding of func-
tional properties ofthe pulmonary endothelium (9,10), a
number of morphological and biochemical characteris-
tics of endothelial cells in culture are now known and
together form a spectrum oftests for identification and
assessment of the quality and purity of pulmonary
endothelial cultures (11,12). Many of these properties
are shared by endothelial cells from other sites (13). In
addition, these tests have provided a standard against
which the relative health of the endothelial cells under
given culture conditions, orin response to experimental
maneuvers or toxic factors, can be assessed.
Isolation of Endothelial Cells from
Pulmonary Artery by Collagenase Digestion
Full details of methods for isolation of endothelial
cells from the pulmonary artery of large animals (such
as cow or pig) have been described (10,12). Segments of
bovine pulmonary artery are obtained as fresh as
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FIGURE 2. Electron micrograph from the alveolar-capillary level of a blood-free rat lung. The capillary endothelial cell is extremely thin in
regions other than the nucleus (N). In transverse section the endothelial cell appears as barely more than two opposing cell membranes in
some areas (asterisk) and inothersthe mostprominent subcellularspecializations are thelarge numbers ofcaveolae, many ofwhich are on the
luminal plasma membrane. Endothelial tight junctions are indicated by arrowheads. x 10,000.
possible from a slaughterhouse. The vessels are rinsed
in sterile Dulbecco's phosphate-buffered saline (PBS)
with calcium and magnesium (Gibco, Grand Island,
NY), pH 7.4, containing 200 U/mL penicillin, 200 ,i/mL
streptomycin, and 325 ,ug/mL fungizone. Cells are ob-
tained by an adaptation of the method of Maruyama
(14), similar to the modifications ofJaffe et al. (15) and
Gimbrone et al. (16).
Each pulmonary artery is separated from the heart
and aortic tissue and stripped of extraneous fatty and
connective tissue. The artery is then washed in two
changes of Dulbecco's PBS with 3x antibiotic concen-
tration. The artery is then placed in a large beaker of
cold Dulbecco's PBS with 3x antibiotics on ice and
placed in the cold room for 2 hr to reduce the likelihood
of bacterial contamination. The arteries are removed
individually and trimmed of any extra tissue and heart
fragments. The end ofthe vessel where it branches into
the left and right pulmonary arteries is tied offusing a
surgeon's knot and 0 surgical silk (or a large hemostat).
The artery is drained of any remaining PBS and then
filled with an 0.25% solution of collagenase (CLS II) in
Dulbecco's PBS at 37°C. The other end ofeach artery is
then clamped by using a large hemostat. The artery is
then suspended and covered in a large beaker of PBS
(prewarmed to 37°C) and placed in a shaker water bath
at slow speed for 25 min. The artery is removed, blot-
ted on sterile tissue, and then suspended by the
ligature over a conical centrifuge tube. The clamp is
opened and the enzyme-cell suspension is collected in
the tube. Each artery is rinsed once with Dulbecco's
PBS and the rinse collected in the same tube. Tubes are
capped and centrifuged at 1OOOg for 10 min at 4°C. The
supernatant is discarded and the pellet washed two
times with cold medium 199 (without FBS). The final
pellet is then resuspended in 2.1 mL medium 199
containing 0.1 mL/100 mL Biostat 100. A 0.1 mL
portion of suspension is counted in a hemocytometer to
determine seeding density. We have found seeding
densities of1.5 to 3 x 105perT25 flaskinatotal of5 mL
ofmedium to be satisfactory. However, hemocytometer
counts of the original seed are not accurate since
endothelial cells are best seeded as small clumps rather
than as monodispersions (Fig. 3) (11,12). The flasks are
capped loosely and placed in a CO2 incubator at 37°C
(5% CO2). Flasks reach confluency within 14 days.
Medium is changed every 2 days.
Isolation of Endothelial Cells from Small
Vessels of the Lungs by Perfusion with
Collagenase
Techniques for the isolation of endothelium from the
microvasculature of the lungs of small laboratory ani-
mals by retrograde perfusion with collagenase have
been described in detail(11) the rabbitlungsbeingused
as an example. For contrast, a similar technique for
obtaining endothelial cells from rat lungs by forward
perfusion with collagenase is described here. This
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FIGURE 3. Phase contrast micrograph ofan initial isolate ofbovine pulmonary artery endothelial cells. The cells are seeded as small clumps or
sheets rather than as monodispersion. x200.
technique has the advantage that it is readily adaptable
for use with a lobe oflung of a larger animal such as pig
(10). In both cases, the principle is the same: the lungs
are perfused blood-free with physiological saline fol-
lowed by perfusion with an enzyme mixture to loosen
the endothelial cells which are then collected via the
vasculature. In all cases where cells are collected viathe
vasculature, retrograde perfusion at the enzyme step
tends to increase the yield. Otherwise loosened cells
may tend to be sieved by the capillaries.
Young female Sprague Dawley rats (80-100 g) are
used. The rats are anesthetized with an intraperitoneal
injection of sodium pentobarbital, 50 mg/kg body
weight. A tracheostomy is performed, and the lungs are
ventilated mechanically with a Harvard respirator (80
strokes/min, 2 mL tidal volume). Heparin, 500 units in
0.5 mL, is injected into the left femoral vein. The chest
and abdominal cavities are opened with a midline
incision and the rib cage is removed taking care not to
cut major blood vessels. The pulmonary artery and
aorta are exposed and ligatures are placed around each
vessel. An 18-gauge Teflon catheter is inserted into the
pulmonary artery and secured with a ligature. The
lungs are pumped with HEPES Dulbecco phosphate-
buffered saline (Process and Instruments Corp. Model
4) at 4 mL/min. As soon as the catheter is secured in the
pulmonary artery, the aorta is cut at the level of the
diaphragm. A second 18-gauge Teflon catheter is in-
serted in the ascending aorta, and the tip is advanced
through the aortic valves into the left ventricle. The
catheter is secured with a ligature. The aortic catheter
is attached to a large drain tube (approx. 1/8 in. internal
diameter) and the drain tube is positioned such that its
outlet is approximately 10 cm below the level of the
heart. The effluent is collected into a beaker. After 10
min of continuous pumping, the effluent is essentially
free ofblood. The lungs are then pumped with medium
199 containing 0.25% collagenase (Worthington CLS2,
pH 7.4) and 4 g-% ofbovine serum albumin (BSA). The
effluent is collected into a series of 10-mL conical
centrifuge tubes (ca. 10 mL of effluent/tube). Each of
the tubes contains medium 199 with 10% fetal bovine
serum (FBS). The collection is stopped when the lungs
become grossly edematous (ca. 30 min), at which time
the drain flow ceases.
The effluent samples are centrifuged at 4°C, 50g for 5
min to sediment any contaminating red blood cells. The
supernatants are transferred to clean centrifuge tubes
and then centrifuged at 10OOg at 4°C for 10 min. The
supernatant after the second centrifugation is removed
by aspiration. The pellets are then washed three times
with fresh medium 199 plus 10% FBS. Each pellet is
resuspended, in 1 mL of the same solution. When the
pellet is evenly suspended, a 0.1 mL sample is placed
into each well of a Falcon eight-well dish and the
remaining suspension is counted in a hemocytometer.
Each sample is then diluted with 1 mL of medium 199
plus 10% FBS.
Each Falcon eight-well dish is incubated for 1 hr at
37°C in an atmosphere of5% CO2 and air. At the end of
the incubation, the medium is removed by aspiration
and is replaced with 2 mL ofmedium 199 plus 10% FBS
plus antibiotics (Biostat 100, 0.1 mL/100 mL medium).
The cells which attached during the first incubation are
incubated again and medium is changed every 72 hr.
When the cells reach confluency (6 to 14 days, depend-
ing on seeding density), they are removed bytrypsiniza-
tion and seeded into 25 cm2 culture flasks.
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Culture and Subculture of
Pulmonary Endothelial Cells
With either of the methods of harvest described
above, endothelial cells grow to form confluent monolay-
ers within 14 days. After an initial medium change 24 hr
after seeding, the medium (M199 + 10% FBS) is
changed weekly. The approximate density at confluence
is 3 x 106 per T25 flask.
The cells can be subcultured as follows. Flasks are
washed for about 10 min with 5 mL of Ca2+ and
Mg2`-free Puck's saline at 37°C. The saline wash is
aspirated off and the cells are incubated with 0.05%
trypsin with 0.02% EDTA in Ca2+ and Mg2e-free
Puck's saline (5 mL at 37°C). The cells are monitored on
an inverted microscope to determine the optimal length
of time of exposure to the trypsin-EDTA solution. We
have found that after 3 min the small, polygonal
endothelial cells begin to lift offwhile the larger, flatter
smooth muscle cells still adhere to the flask. With a
minimum of agitation, the enzyme mixture containing
cells is transferred, by using a 5-mL pipet, to 15-mL
conical centrifuge tubes. The cells are centrifuged at
750g for 10 min. The trypsin solution is removed by
aspiration, and the pellet is resuspended in a small
quantity ofmedium 199 without fetalbovine serum. The
flasks are usually split two for one. Each new flask is
seeded with approximately 105 cells. The doubling time
forbovine pulmonary artery endothelialcellsis about20
hr. Flasks which are predominantly endothelial (less
than 5% contamination with smooth muscle cells) can be
purified by successive subculture, taking advantage of
the difference in attachment and detachment rates of
the two cell types. Trypsin preferentially detaches
bovine endothelial cells; thus, short periods (2-3 min) of
exposure to trypsin prior to transferring cells tend to
leave smooth muscle cells adherent to the flasks.
Furthermore, endothelial cells are the first to reattach.
Hence, cells are seeded into new flasks and incubated
for 1 hr at 37°C. Medium and any free-floating cells are
removed by aspiration and replaced with fresh medium
containing fetal bovine serum and antibiotics.
Isolation Avoiding the Use of
Proteolytic Enzymes
Despite much recent progress in the culture of
endothelial cells, few if any laboratories have succeeded
in establishing long-term cultures of endothelial cells
which maintain a cobblestone monolayer morphology,
division rates and differentiated characteristics of
endothelium. Gospodarowicz et al. (17) have succeeded
in carrying cultures of bovine heart endothelial cells
through alarge number ofpassages by addingfibroblast
growth factor (FGF). However, two serious problems
have been encountered. First, the cells are virtually
impossible to wean from FGF, an extremely expensive
culture medium additive. Second, and perhaps most
importantly, the cells tend to lose functional properties.
The factors responsible for in vitro aging ofcells have
not yet been determined, but repeated exposure to
trypsin is likely to contribute to accelerated aging.
Quite clearly, there are serious limitations to what can
be learned from a line of cells in culture that do not
retain characteristics ofthe same cells in situ. We have
therefore begun to develop new techniques for the
culture of pulmonary endothelial cells which avoid
exposure to proteolytic enzymes at both the isolation
step and during successive passages. In studies pub-
lished recently (18) we have described techniques for
the mechanical isolation of pulmonary artery endothe-
lial cells by scraping with a scalpel.
Fresh plucks (heart and lungs with attached great
vessels) are obtained from a slaughterhouse as before;
veal or young calfmaterial is preferable. The outside of
the preparation is cleaned with a towel soaked in 70%
ethyl alcohol. Pulmonary artery is dissected free from
the pericardium and aorta and extraneous fatty and
connective tissue is stripped away. The pulmonary
artery is removed and placed in Puck's saline. If time
allows, bacterial contamination is reduced ifarteries are
held in Puck's containing 3x antibiotics for 1 hr in a
cold room (4°C). Then, under a laminar flow hood, the
pulmonary artery is slit open so that it lies flat and
draped over the edge of a Petri dish. The luminal
surface is scraped with a sterile scalpel (No. 11 blade)
usinglight, single strokes, coveringeach area once only.
The cells which build up on the scalpel blade are shaken
offinto atube ofMedium 199containing antibiotics. The
cells are sedimented atapproximately lOOgfor 10 min at
4°C and the supernatant is decanted. The cells are
resuspended in Medium 199 containing 10% FBS and
centrifuged again. The pellet is pipetted several times
to breakup large clumps ofcells andthe cells are seeded
into T25 flasks or 35 mm2 Petri dishes.
Cells collected by mechanical harvest have been
particularly useful for studies where the original polar-
ity of the cells must be preserved such as studies of
endothelial junctions. The morphology of the junctions
is an important indication ofthe size ofthe vessel from
which the cells were obtained. Figure 4 shows a replica
ofa freeze-fractured endothelialjunction obtained from
pulmonary artery and indicates a complex oftight and
gap junctional elements similar to the arrangement in
vivo (18).
However, initial isolates are not suitable for studies
requiring large numbers of uniform cells. Scale-up of
cultures implies growing the cells over many passages
(see below).
Long-Term, Large-Scale Culture of
Endothelium Avoiding the Use of Enzymes
Bovine pulmonary artery endothelial isolates that are
harvested mechanically can be seeded onto culture
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FIGURE 4. Replica offreeze-fractured endothelial isolate indicating tightjunctions comprised ofstrands ofdiscontinuous particles (arrows) on
the E face and bybarelyperceptible ridges on the P face. The crest ofthe ridge may contain occasional particles but not in any regular linear
array. Sometimes the ridge appears to extend into small irregular gapjunctions. In other areas the gapjunctions may be more extensive (*)
and may flank the network of tight junctional strands. Reproduced with permission from Ryan et al. (17).
flasks, maintained as monolayer cultures and passaged
nonenzymatically by screping with a rubber policeman
followed by transfer to\new flasks. This technique is
time-consuming, and the cells tend to settle in clumps
even if passed through a 30-gauge needle and reach
confluence more slowly than cells passaged using
trypsin/EDTA (18).
However, microcarriers, e.g., Bio-Carrier polyacryl-
amide beads (Biorad), Cytodex (Pharmacial), Biosilon
(Nunc) or specially coated polystyrene microcarriers
(19), provide a substratum suitable for obtaining high
yields of endothelial cells in culture, that can be
passaged with simplicity without using enzymes.
Spinner flasks are the vessels recommended for
microcarrier culture by the manufacturer but roller
bottles (Bellco) appear to be highly satisfactory pro-
vided they are rotated at the highest speed setting.
Pulmonary artery endothelial cells can be seeded di-
rectly onto microcarriers from fresh isolates or from
monolayer cultures. The cells attach to the beads
rapidly, for example after 5 min, about 25 to 30% beads
have one or more cells attached to them. After 10 min,
about 50% beads have one or more cells attached and
some have three or four cells. After 20 min, the cells
spread out on the beads, and many division figures are
apparent after24 hr. Endothelial cells onbeads have the
cobblestone morphology characteristic of these cells in
monolayer culture (Figs. 5 and 6).
Endothelial cells were found to attach to beads of all
sizes; at confluence large beads (200 ,um in diameter)
would carry 90 to 100 cells while smaller beads (100 ,um
in diameter) might have 40 to 50 cells attached.
The theoretical surface area for cell attachment using
microcarriers is enormous: 2 x 109 cells per dry gram of
Bio-Cariers (19). The concentration of beads per liter
ofculture medium can be varied considerably. We have
found that, at confluence, 1 x 106 beads per 10 mL of
medium yield about 2.2 x 107 cells (2.2 x 109). Cultures
split 1:2 at this density replicate well. A corresponding
10 mL ofmedium would support approximately 3 x 10'
endothelial cells in monolayer culture. The cells grow to
confluence on each bead but at anytime free cells can be
found in suspension and colonization of fresh beads
presumably occurs both from free cells in suspension
and from other beads (Fig. 5) (17,20).
Microcarrier cultures can be initiated from fresh
isolates, from a healthy monolayer culture in log phase
or directly from blood vessels (21). The bead cultures
are maintained in the same medium (M 199 with 10%
FBS), with addition of 24 mM HEPES to compensate
for the air atmosphere in the Bellco roller bottle
incubator. The cultures are seeded into larger roller
bottles (1 L, designed for the Bellco) or into smaller
bottles of 100 mL or 500 mL capacity secured in a large
cylindrical vessel. The bottles are coated with Siliclad to
prevent sticking of beads or cells to the bottle walls.
However, high yields ofendothelial cells canbe obtained
if cells are allowed to replicate on the walls of
unsiliconized roller bottles as well as on the beads.
Concentrations of cells and beads can be varied,
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FIGURE 5. Bovine pulmonary artery endothelial cells in microcarrier culture. These cells were harvested mechanically and have never been
exposed to proteolytic enzymes. They were seeded onto polyacrylamide beads 4 days previously and maintained in a roller culture. The cells
are not yet confluent on each bead (compare Fig. 6). x260.
FIGURE 6. Polyacrylamide bead from aculture similar to that shown
in Fig. 5 but approximately 8 days after seeding. The cells are
almost confluent on each bead, cells in division can still be seen
(arrow). x260.
within wide limits. Primary cultures grow well if the
cells are seeded in a 100 mL bottle, using 8.0 mL
medium, 1.0 mL bead suspension and 1.0 mL cell
suspension (approximately 1 x 106 cells/mL). The
bottle is swirled gently to mix ingredients, capped
tightly and placed in the roller apparatus at 37°C with
rotation speed set at the maximum. The cells attach
within 20 min, and division occurs after 24 hr. The
medium is changed every 3 to 4 days.
Subculture. To subculture without using enzymes,
the bead culture is evenly suspended and divided into
two equal parts. Fresh medium and fresh beads are
added. The cells rapidly colonize the new beads. This
procedure can be repeated twice weekly. The split ratio
can be as high as 1:10, 1 mL ofcell-covered beads being
used to seed a new flask.
Cells canbe transferred from microcarrier cultures to
flasks and vice versa at any stage. To transferto aflask,
0.5 mL of an even suspension of cell-covered beads is
placed in a25cm2flask, and 9.5mL ofmediumis added.
The cells 'crawl" off the beads and establish a mono-
layer on the flask in 5 to 6 days (18,21). As the cells
detach from the beads, most of the loose beads are
removed when the medium is changed.
In order to transfer cells from flasks to microcarriers
quickly without using enzymes, the endothelial mono-
layer is scraped with a rubber policeman, collected in a
3-mL syringe, passed through a 30-gauge needle to
break up large clumps of cells, and seeded onto
microcarriers as described for initial seeding of fresh
isolates. Alternatively, microcarriers can be introduced
into flasks containing confluent monolayers. Endothelial
cells colonize the microcarriers which can then be
transferred to flasks (21).
Sampling Microcarrier Cultures. The roller bot-
tles are swirled to be sure that all the beads are in
suspension. Under sterile conditions a sample of bead
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suspension is withdrawn, no more than 5% by volume.
A 25 p1L portion of an even suspension of a micro-
carrier cultures is placed on a 35-mm gridded culture
dish. The droplet is stained by mixing it with a small
amount of methylene blue by means of a wooden
applicator stick or toothpick. The drop is then covered
with a 22-mm glass coverslip (see Figs. 5 and 6).
Since the beads are transparent, it is possible to focus
through the bead and assess the total surface area. In
this manner, it is possible to keep an accurate count of
the total number of cells per milliliter culture.
Cloning. Unstained preparations mayalso be exam-
ined by phase contrast microscopy. At a seeding density
of about one cell per two beads, cells are selected for
cloning. By means of a small capillary tube (or
micropipet) individual beads with one adherent cell are
transferred to a microwell plate for cloning.
Removal of Cells from Beads by Vortexing. A
number of procedures such as electron microscopy,
countingin ahemocytometer, enzyme assaysand subcul-
ture are sometimes more conveniently performed us-
ing cells removed and separated from beads. A quick,
easy, reproducible and enzyme-free method for the
removal of endothelial cells from Bio-Carriers is as
follows: Plasticware or siliconized glassware is used
throughout to prevent loss of cells or beads by sticking
tothe walls ofvessels. Anappropriate volume (generally
1-10 mL) ofcell-bead suspension (thoroughly and evenly
suspended) is withdrawn from the roller bottle under
the laminar flow hood and placed in a centrifuge tube.
The tube is vortexed (outside rim) for 2 min at a setting
of 5. The suspension is passed through a 44 ,um filter
previously handcut from a roll of nylon monofilament
mesh and fitted to a Swinex filter holder. The swinex
holder is attached to a disposable syringe (3 mL). If
necessary any beads adhering to the walls of the test
tube are washed with fresh medium and filtered. The
beads (80-200 ,um, as supplied) are retained by the
nylon mesh, and the endothelial cells pass through.
Identification of Endothelial Cells
Cells obtained by any of the above methods are
readily identifiable as endothelial according to morpho-
logical and functional criteria (12). When examined in
the inverted microscope by phase contrast microscopy,
the cells grow as monolayers with a cobblestone appear-
ance characteristic of endothelium (Fig. 7). When
examined in the electron microscope, they contain all of
the cellular organelles expected of pulmonary artery
endothelial cells in situ (Figs. 8-10). The cells are
routinely examined by electron microscopy of thin
sections of monolayers still attached to the culture
flasks (Fig. 9) (10,12). However, we have developed
means ofexamining the cells in culture without removal
from the culture flasks by additional techniques includ-
ing freeze-fracture of monolayers, scanning electron
microscopy, and examination of surface replicas (9,
22,23). Similarly endothelial cells on polystyrene micro-
carriers can be examined by scanning and transmission
electron microscopy (18). Thus, we are now able to
recognize a variety of views of endothelial cells. In
addition, ourcultures possess functional aspects charac-
teristic of endothelial cells. The cells possess angioten-
sin converting enzyme activity as demonstrated by
using [125ILyr8-bradykinin as substrate (24) and a
variety of synthetic substrates (25). In addition, the
cells are reactive with antibodies to angiotensin convert-
ing enzyme, as can be shown with immunofluorescence
microscopy and immunocytochemistry (9,10). Using the
latter technique, we were able to localize angiotensin
converting enzyme on the plasma membrane and
caveolae ofendothelial cells in culture, aresult in accord
with ourprevious demonstration ofangiotensin convert-
ing enzyme on the luminal surface of pulmonary endo-
thelial cells in situ. Bovine endothelial cells also react
with antibodies to human factor VIII and a2-macro-
globulin, and this we have demonstrated by immuno-
fluorescence (11,12). The lack of Fc receptors on unin-
jured pulmonary endothelial cells in culture (26) indi-
cates that nonspecific binding of IgG need not be of
concern in immunofluorescence studies.
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FIGURE 7. Phase contrast micrograph of a confluent monolayer of
bovine pulmonary artery endothelial cells in their 12th passage.
The 'cobblestone" morphology has become one ofthe hallmarks of
a healthy endothelial culture. x250.
110PULMONARY ENDOTHELIAL CELL CULTURE
FIGURE 8. Electronmicrograph ofbovinepulmonary arteryendothe-
lial cells freshly isolated by scraping with a scalpel. In addition to
caveolae on the luminal surface (arrow) Golgi apparatus (G) is
apparent near the nucleus, and fibrillar material is evident below
the nucleus (asterisk), rough endoplasmic reticulum is distributed
throughout the cytoplasm. x20,000.
Discussion
Pulmonary endothelial cells in culture have been used
to demonstrate, in vitro, a number of other properties
or lung functions, which are not at present used as
criteria for identification of endothelial cells.
FIGURE 9. Low power electron micrograph of pulmonary artery
endothelial cell in monolayer culture. Sections were cut without
removal ofthe cells from the culture flask (F). The single layer of
cells and the flattened morphology, except in the region of the
nucleus, the caveolae along the upper surface and the intracellular
organelles characteristic of the cell in situ (Fig. 8) persist in
culture. x 7800.
For example, pulmonary endothelial cells are capable
of forming prostaglandins and related substances from
1-'4C-arachidonate. Using EM autoradiography ofcells
incubated with [3H]-acetyl salicylate (a specificinhibitor
ofprostaglandin synthetase), we were able to show that
the enzyme is situated on the endoplasmic reticulum
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FIGURE 10. Electron micrograph ofanenface section ofanendothelial cellinculture. Theplane ofsectiongrazesfromthe culture flask(F) tothe
nucleus (N). Large numbers ofcaveolae (arrows) are present at the periphery ofthe cell. Mitochondria (M) and obliquely sectioned cisternae
ofthe rough endoplasmic reticulum (asterisk) indicate that endothelial cells in culture contain abundant intracellular organelles which are not
shown to advantage in transverse sections (e.g., Fig. 9). x 14,000.
(11,12). PGE2 and PGI2 are the major metabolites.
Synthesis of PGI2 by endothelial cells has been de-
scribed by a number oflaboratories (27-29). It is likely
that all or part ofthe PGI2 formed by lungs arises from
endothelial cells.
Intact blood vessel walls are known to have anti-
thrombotic properties, thought to be associated with
the endothelial cell lining layer. As mentioned above,
endothelial cells in culture can synthesize prostacyclin
(PGI2), a substance which canpreventplatelet aggrega-
tion and also disaggregate platelet clumps. The lungs
can also degrade the potent, platelet aggregating agent
adenosine-5'diphosphate (ADP) (30). Pulmonary endo-
thelial cells in culture can rapidly degrade ADR The
first product formed is 5'-AMP, which is itselfdegraded
to yield adenosine and inosine. Adenosine does not
accumulate in the medium but is taken up by the cells
and incorporated into ADP and then into ATP (31).
Thus, in addition to their ability to synthesize PGI2,
pulmonary endothelial cells can degrade ADP and
together these properties may account for the capacity
of endothelial cells to prevent or inhibit platelet
aggregation.
It is now apparent that endothelial cells, especially
those ofthe lungs play akeyrole inthe regulation ofthe
renin-angiotensin andkallikrein-kinin systems (1,32). A
single enzyme: angiotensin converting enzyme or
kininase II can inactivate bradykinin and convert angio-
tensin I to angiotensin II, this enzyme, which links the
two systems, is situated on the luminal surface of
pulmonary endothelial cells in situ (1,10) and in culture
(10,12). The enzyme probably occupies a similar posi-
tion in other vascular beds (33). In the case of pulmo-
nary endothelial cells, we have been able to show that
the cells not only possess the enzyme but that they are
able to synthesize it in culture (12). In this regard,
transverse sections (Figs. 2, 8 and 9) do not give an
appreciation ofthe intracellular machinery required for
synthesis. However, enface sections (Fig. 10) illustrate
that endothelial cells possess the full complement of
intracellular organelles required for enzyme synthesis
but disposed within the very flattened shape of the
cells.
Thus, one can readily isolate and culture endothelial
cells from pulmonary artery of, for example, cow
(9,10,12). These cultures have provided useful informa-
tion on specific metabolic activities ofpulmonary endo-
thelium and have the advantage that large quantities of
cells can be obtained in original isolates. In addition,
antigenic sites ofbovine cells appearto cross-react with
antibodiesto humanantisera. However, thevastprepon-
derance of studies on metabolic functions of the lungs
have been performed with small animals, in which it is
virtually impossible to obtain an adequate number of
cells from main-stem pulmonary artery. Furthermore,
although we and others have shown that cells for
main-stem pulmonary artery are capable of metaboliz-
ing bradykinin, angiotensin, ADP, adenosine, and bio-
genic amines, the general assumption is that the
processing of such substances in vivo occurs most
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prominently at the level of the microcirculation. New
techniques of cell isolation by vascular perfusion allow
use of small animals and therefore allow a more direct
comparison with previous functional studies in which
small animals, such as rats and rabbits, have been used
(11,20).
To extend the scope of studies which can be under-
taken of pulmonary endothelial functions, we have
developed means ofobtaininglarge numbers ofendothe-
lial cells in long-term culture which avoid repeated
exposure to proteolytic enzymes. The factors involved
in the aging process of cells in culture are not fully
understood but repeated exposure to trypsin is likely to
contribute to accelerated aging; loss ofsurface enzymes
and alterations in size, shape and junctional contacts,
together with progressively slower and asynchronous
rates of division. To assess this last feature, we have
examined our enzyme-free cell lines by time-lapse
cinematography. Further, there is a high correlation of
interdivision times and migration distances between
daughter pairs (34). The cells are remarkably mobile
and, by comparison with lung fibroblasts of high pas-
sage number (35) our cells show no indications ofaging.
The cobblestone morphology is preserved as are angio-
tensin converting enzyme, Factor VIII antigen and
junctional contacts.
The bead cultures have the advantage of providing a
system for the long-term, large-scale culture of pulmo-
nary endothelial cells, features which to a large extent
determine the scope ofbiochemical studies which canbe
undertaken. However, an additional advantage (which it
is perhaps still too early to assess completely) is that a
method now exists for culturing large numbers of
endothelial cells which have never been exposed to
exogenous proteolytic enzymes or growth factors and
which retain the differentiated characteristics of pri-
mary cultures.
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